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Abstract 
Targeting mitochondrial ion homeostasis using Kaempferol, a mitochondrial Ca2+ 
uniporter channel activator, improves energy metabolism and behavior soon after a 
traumatic brain injury (TBI) in developing rats. Due to broad TBI pathophysiology and brain 
mitochondrial heterogeneity, Kaempferol mediated early-stage behavioral and brain 
metabolic benefits may accrue from diverse sources within the brain. We hypothesized 
that Kaempferol influences TBI outcome by differentially impacting the neural, vascular 
and synaptic/axonal compartments. Following TBI at early development (P31), fMRI and 
DTI were applied to determine imaging outcomes at adolescence (2-months post-injury). 
Vehicle and Kaempferol treatments were made at 1, 24 and 48 hrs post-TBI and their 
effects were assessed at adolescence. A significant increase in neural connectivity was 
observed after Kaempferol treatment as assessed by the spatial extent and strength of the 
somatosensory cortical and hippocampal RSFC networks. However, no significant RSFC 
changes were observed in the thalamus. DTI measures of fractional anisotropy (FA) and 
apparent diffusion coefficient (ADC), representing synaptic/axonal and microstructural 
integrity, showed significant improvements after Kaempferol treatment, with highest 
changes in the frontal and parietal cortices and hippocampus. Kaempferol treatment also 
increased corpus callosal FA, indicating measurable improvement in the inter-hemispheric 
structural connectivity. TBI prognosis was significantly altered at adolescence by early 
Kaempferol treatment, with improved neural connectivity, neurovascular coupling and 
parenchymal microstructure in select brain regions. However, Kaempferol failed to 
improve vasomotive function across the whole brain, as measured by cerebrovascular 
reactivity (CVR). The differential effects of Kaempferol treatment on various brain 
functional compartments support diverse cellular-level mitochondrial functional outcomes 
in vivo. 
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Introduction 
A large inter-dependence exists between neural circuit activity, the cerebrovascular 
supply supporting circuit function and synaptic/axonal microstructure, which act in concert 
to determine systemic sensorimotor and cognitive outcomes. Traumatic brain injury (TBI) 
pathology is broad, affecting multiple cellular types and hence different neurophysiological 
variables 1. TBI leads to an energy metabolic decline in pediatric patients and 
developmental preclinical models of injury, 2-7 consequently affecting downstream 
function in various cellular compartments. 1  Hence mitochondria, the subcellular 
organelles responsible for oxidative energy metabolism, and enriched in diverse cell types 
of the brain are effective targets for TBI treatments.  It can be hypothesized that 
treatments targeting mitochondria can promote diverse cell-type specific downstream 
repair mechanisms in neurons, glia, vascular smooth muscle and endothelium, which can 
synergistically improve neurophysiological outcomes. Since energy metabolism is 
upstream to various cellular processes during recovery from TBI, treatments maintaining 
mitochondrial ion homeostasis, and hence their energy metabolic capacity, may 
differentially impact injury prognosis depending on the mitochondrial properties of each 
brain compartment.  
Preservation of energy metabolism in the developing brain is not only crucial for 
efficient post-TBI repair via downstream energy-dependent mechanisms, but also to 
sustain normal ongoing developmental changes. Since cerebral vasculature, neural and 
axonal/synaptic microstructures dynamically change during development, 8-12 TBI in 
children are more devastating due to impediments of ongoing normal development. Given 
the temporally variable characteristics of TBI pathology 1, preclinical experiments reporting 
on multiple biomarkers of brain function during development, preferably in a 
simultaneous manner and translatable to humans are necessary. Addressing this gap, our 
previous study utilized magnetic resonance imaging (MRI) based functional MRI (fMRI) and 
diffusion tensor imaging (DTI) modalities to simultaneously determine brain structural and 
functional changes at adolescence after TBI using the development rat model. 13  The 
multimodal MRI biomarkers obtained at the adolescent stage strongly correlated with the 
metabolic decline, reduced neural viability and behavioral debilitation observed during the 
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early acute/subacute stage (0-72 hours) after TBI. 2  Acutely targeting mitochondrial ion 
homeostasis using Kaempferol, a pharmacological enhancer of mitochondrial Ca2+ 
uniporter channel (mCU) activity and hence mitochondrial Ca2+ cycling 14,15, mitigated the 
TBI-induced early energy metabolic decline and improved behavioral performance. 16  The 
early-window Kaempferol treatment regimen (1mg/Kg i.p) at 1, 24 and 48 hrs post-TBI, 
also improved prognosis at adolescence revealed by better stimulus-induced 
neurovascular coupling responses and sensorimotor behavior 17.   
Using a translatable experimental design and clinically relevant imaging markers, 
the present study tested the hypothesis that Kaempferol-mediated effects on the brain are 
diverse, through its variable effects on mitochondria in different cellular types. Rats (age; 
P31) underwent a fluid percussion TBI in the mild to moderate intensity and randomly 
assigned to vehicle or Kaempferol (1mg/Kg) groups, where treatments were made at 1, 24 
and 48 hours after injury. Using fMRI and DTI measures at adolescence (2 months after 
injury), various system level biomarkers informing on the neural, vascular and 
synaptic/axonal compartments were determined to assess TBI prognosis and the effects of 
Kaempferol treatment. 
Materials and Methods 
Animals and treatment 
Male Sprague-Dawley rats (n=16; 23-24 days old; weighing 60-80g) were procured 
from Charles River Laboratories, Wilmington, MA, USA and housed in pairs under 
controlled conditions. All experimental on animals were carried out in accordance with the 
protocol approved by a local Institutional Animal Care and Use Committee (IACUC) of 
Rutgers Biomedical and Health Sciences-New Jersey Medical School and Yale University 
School of Medicine. Kaempferol used in the current study was of commercial grade (Signa-
Aldrich, USA) and freshly prepared into working solution using sterile saline. Routes of 
administration for vehicle (10% dimethyl sulfoxide in saline) and Kaempferol were through 
intraperitoneal injection. 
Lateral fluid-percussion injury 
Rats (age; P31) were subject to lateral fluid percussion injury (FPI) as previously 
described. 18,19  The developmental rat age at P31 approximately correspond between 2-4 
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years of human age,20  The FPI method produced diffuse moderate TBI, very similar to that 
observed in humans. Briefly, animals were anesthetized with Ketamine (80mg/kg i.p)-
Xylazine (10mg/kg i.p) and positioned on a stereotaxic frame after confirming surgical 
plane anesthesia. A 3mm craniotomy was performed on the left side of the skull -5 mm 
posterior to the bregma and 3 mm lateral to the sagittal suture while retaining the dura. A 
Luer-Lock syringe hub was attached surrounding the exposed dura using cyanoacrylate 
adhesive. 24 hours after the Luer Lock placement, TBI was induced by attaching the Luer-
Lock hub of each isoflurane-anesthetized animal to the FPI device (Virginia Commonwealth 
University, VA, USA). A pendulum drop delivered a brief 20ms impact on the intact dura. 
The impact pressure was measured by an extra-cranial transducer and controlled between 
1.8-2.0 atm. All surgical and experimental conditions in the current treatment groups were 
kept similar to our prior sham and untreated TBI study for consistency, and which has been 
published recently 13.  Immediate neurological parameters observation after injury did not 
lead to any seizure like behavior in all injured animals. Vehicle and Kaempferol treated-TBI 
animals were monitored within their cage environment on a daily basis. Mortality was 
observed in two vehicle-treated and one Kaempferol treated animal within 3 days post 
injury. Surviving animal groups ie., TBI+vehicle (n=5) and TBI+Kaempferol treatment (n=8) 
underwent the fMRI and DTI measurements for the present study.   
Magnetic Resonance Imaging (MRI) 
MRI experiments were performed at adolescence (2-months after TBI), translating to 
approximately 12-14 years of human age.20,21.  Animals were anesthetized using 
intraperitoneal injection of urethane (1.3 mg/kg body weight). Tracheostomy was 
performed on animals to administer a mixture of O2 and N2O (30/70%) through a breathing 
tube. Animals were then placed into a custom-built frame and fixed to ear-bars to 
minimize motion and produce consistent spatial positioning within the RF coil. Body 
temperature was monitored throughout the procedure using a rectal probe and 
maintained within 35-37ºC using warm water circulated pad. Chronology of anatomical 
MRI, functional MRI and Diffusion MRI measures were randomly varied across animal 
subjects, except the hypercapnic (CO2) stimulation experiments, which was always 
performed last. 
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Anatomical MRI:   
MRI scanning was performed on a modified 9.4T system with Bruker spectrometer and 
custom built 1H ellipsoidal surface coil (5 x 3 cm). MR-images were acquired over 12 
contiguous coronal slices (thickness = 1mm), covering the parenchyma between the 
olfactory bulb and cerebellum, with an in-plane field of view of 3.2 x 2.4 cm.  Anatomical 
reference images (TR/TE = 4000/30 ms, 2 averages) were acquired in a 128 x 96 matrix, 
using a RARE sequence providing an in-plane resolution of 250 x 250 µm.   Additionally, a 
fast 3D anatomical scan (TR/TE = 50/5.6 ms, FA = 20º, 2 averages) was acquired with an 
isotropic resolution of 250 µm, for image registration purposes. 
Diffusion MRI:  
Diffusion sensitive images for DTI (TR/TE = 4000/20 ms, 4 averages) was acquired as a 4-
segment EPI in a 64 x 48 matrix (in-plane resolution = 500 x 500 µm), with 5 A0 images, 15 
diffusion directions and a b-value of 1000 s/mm2.  
Resting state and cerebrovascular reactivity fMRI:  
Resting state and cerebrovascular reactivity fMRI were performed using the gradient echo 
(GE) echo planar imaging (EPI) sequence (TR/TE= 1000/15 ms, preceded by 8 dummy 
scans) using the same geometry as diffusion scans (64 x 48 matrix, 500 x 500 µm in-plane 
resolution)  with the GE-EPI sequence producing image contrast sensitive to blood 
oxygenation changes (BOLD). 22  Resting-state fMRI paradigm consisted of a 5 min scan 
(300 repetitions), acquired in four experimental trials per animal.  Cerebrovascular 
reactivity fMRI scans were obtained using similar GE-EPI parameters as the resting state 
fMRI which lasted for 12 minutes (720 repetitions). A 10% carbon dioxide gas (CO2) added 
to the breathing gas mixture of O2 and N2O (30/70%) between minutes 3 and 6 of the 
acquisition and repeated twice per animal.  
Data analysis and statistics: 
 All EPI images were linearly registered to the subject’s native anatomical space 
before further processing.  BioImage Suite software (http://bioimagesuite.yale.edu/) was 
used for the tensor model fitting on a voxel-wise basis using the diffusion sensitive images. 
Parametric maps of fractional anisotropy (FA) and mean diffusivity (MD) value maps were 
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obtain as described in our earlier studies. 23  Blood oxygen level dependent (BOLD) fMRI 
temporal EPI data sets obtained during the resting state and CO2 challenge experiments 
were analyzed using the AFNI software. 24  EPIs were corrected for slice-time using 3dTshift 
and motion using 3dvolreg with the 5th sub-brick as the base. EPIs were subsequently 
spatially smoothed using a Gaussian filter (FWHM = 1.5 mm) and linearly detrended to 
remove temporal signal drifts for resting-state scans only.  No detrending was performed 
on the CO2 scans to avoid biasing the BOLD response curve to the single event CO2 
challenge. Our previous quality control scans with the same sequence showed no 
significant linear drift within 12 minutes the typical length of one CO2 challenge 
acquisition. Parametric maps of CO2 challenge-induced cerebrovascular reactivity were 
generated from a voxel-level linear model based on the “ON” and “OFF” timing of CO2 gas 
delivery and expressed as the t-statistical value of the contrast between baseline (Frames 
1 to 180) and CO2 challenge (Frames 210 to 360).   
For resting-state functional connectivity (RSFC) analysis, preprocessed EPIs were 
band pass filtered (0.01 to 0.15 Hz). Six seed voxels were chosen from each region of 
interest (ROI) from the right hemisphere (contralateral to the injury). The ROIs were 
somatosensory cortex, hippocampus and thalamic regions ensuring that the seed voxels 
randomly identified always lie within these respective ROIs identified using the rat brain 
atlas. 25  Signal time series from each selected seed voxel was cross correlated with the 
entire brain, producing 6 cross-correlation maps for each experimental trial. As 
demonstrated in our earlier studies in normal 26 and TBI animals, 13  the average RSFC map 
obtained from the six different cross-correlation maps represented a more accurate 
topology of the RSFC network. In a similar manner, the 6 correlation maps obtained using 
6 random seed voxels within each respective ROI (somatosensory cortical, hippocampus 
and thalamus) were obtained for each resting state scan leading to 18 correlation maps for 
3 experimental trials performed on each animal. Subsequently all correlation maps were 
averaged across trials and animals in each group. A Fisher z-transformation was used to 
convert the correlation coefficients to z-scores before averaging.  After averaging, an 
inverse transform was subsequently used to obtain voxel-wise average correlation 
coefficient values in the group RSFC maps. 
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 For group statistical comparisons, 3D anatomical images were used to generate a 
non-linear transform from each animal subject’s native space to a common space, 
consisting of an averaged brain from 8 sham animals obtained from our earlier analysis of 
sham animals 13.  Since a small ipsilateral distortion occurred along the skull and 
parenchymal area (injury epicenter) where a fluid percussion Luer Lock existed to enable 
the fluid percussion traumatic brain injury a non-linear registration was used for the final 
statistical parameters.  Registered anatomy from each animal subject was visually 
inspected for alignment by overlaying the registered images on the average-sham 
anatomical MRI template. Subsequently the respective transforms were applied to all 
parametric maps of FA, ADC, CVR and RSFC networks obtained from all TBI animals (both 
vehicle and Kaempferol-treated).  Regions of interest (ROIs) included the cortex, 
hippocampus, thalamus, hypothalamus, amygdala and white matter areas such as the 
corpus callosum, internal capsule and cingulum. ROIs were drawn on the co-registered 
average sham brain using the rat brain atlas, 25 and used across each co-registered 
individual brain (Supplementary Figure S1). Similar to our earlier analyses of the sham and 
untreated-TBI groups, 13 the cortical ROIs encompassed motor, somatosensory, parietal, 
auditory, visual, perirhinal and entorhinal areas for consistent comparisons 
(Supplementary Figure S1).  For each modality, group differences were calculated using a 
voxel level general linear model (t distribution), with treatment as the contrast and 
standard deviation calculated at each voxel. Significance was defined as a threshold of 
p<0.05 after correcting for multiple comparisons using a random field theory approach, 
accounting for the cluster size of contiguous significant voxels. 27  
Results 
Multimodality imaging with DTI-based fractional anisotropy (FA) and apparent diffusion 
coefficient (ADC) variables were used as markers of brain parenchymal changes, which is 
known to correlate with synaptic/axonal microstructure.  fMRI-BOLD based resting state 
functional connectivity (RSFC) was used as a marker of neural circuit activity and transient 
hypercapnia-induced fMRI-BOLD as a surrogate for cerebrovascular reactivity (CVR). 
Together these parameters provide a multidimensional assessment of the effects of 
Kaempferol treatment in improving outcomes of developmental TBI. 
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In our prior studies, comparison of DTI responses between sham and TBI groups 
revealed a significant reduction in FA and increased ADC, spreading bilaterally and across 
the inter-hemispheric white matter regions such as the corpus callosum. 13  Specifically, 
bilateral FA decreases were observed in the somatosensory and entorhinal cortices, 
whereas unilateral FA decreases were prominent in the ipsilateral cingulum and internal 
capsule regions of interest (ROIs).13  ADC values between sham and TBI in our previous 
studies increased significantly in the same ROIs, indicating increased isotropic diffusion 
after TBI and consistent with the decreased FA. 13  In the current study comparing 
Kaempferol and vehicle treatments in TBI animals, strong unilateral and bilateral increases 
in FA occurred after Kaempferol treatment when compared to vehicle (Figure 1A).  As 
observed by the group statistical maps of vehicle vs Kaempferol, FA increases were mostly 
across the peri-lesional regions away from the injury epicenter (Figure 1A).  Unilateral FA 
increases were observed within the ipsilateral perirhinal cortex, hippocampus, 
hypothalamus, thalamus and amygdala, whereas bilateral FA increases were observed 
across motor, somatosensory cortices, insula and caudate putamen (Figure 1A). FA 
increase with Kaempferol treatment across various anatomical regions statistically 
determined in Figure 1A are depicted in the supplementary Figure S2B. Significant 
Kaempferol-induced microstructural integrity improvement as determined by increased FA 
was observed in various white matter ROIs, including the corpus callosum and across both 
hemispheres in the cingulum and internal capsule (Figure 1B).  ADC values decreased after 
Kaempferol treatment compared to vehicle.  Although ADC decreases were relatively 
sparse compared to FA, the group statistical maps indicated highly specific ADC decreases 
across ipsilateral cortical regions, hippocampus, internal capsule and bilaterally across the 
hypothalamus (Figure 1C).  ADC changes determined across different white matter ROIs 
showed significant ADC decrease only across the corpus callosum after Kaempferol 
treatment when compared to vehicle (Figure 1D). ADC decrease after Kaempferol 
treatment across various anatomical regions statistically determined in Figure 1B are 
depicted in the supplementary Figure S2D.  Taken together with our prior results of 
untreated TBI versus sham 13, the current DTI results after treatment highlights the 
protective effect of Kaempferol not only in the most vulnerable regions after TBI such as 
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the perirhinal cortex, hippocampus, hypothalamus, thalamus, amygdala, and corpus 
callosum, but also across additional structures such as the insula and caudate putamen.  
From our previous studies, all RSFC networks (somatosensory cortical, hippocampal and 
thalamic seed voxels) were observed to have higher bilateral symmetry in sham compared 
to TBI animals. A significant ipsilateral decrease in RSFC network spatial extent was 
observed in TBI when compared to sham. 13  In the current treatment study, all RSFC 
networks (somatosensory cortical, hippocampal and thalamic) showed similar ipsilateral 
RSFC spatial extent decrease in the vehicle-treated TBI animal group (Figures 2A,3A and 
4A), and comparable to the untreated TBI group observed earlier 13. Kaempferol’s effect 
on RSFC was investigated by comparing the vehicle- and Kaempferol treated TBI groups 
across the somatosensory cortical, hippocampal and thalamic RSFC networks. A significant 
bilateral increase in RSFC network spatial extent occurred across the cortical and 
hippocampal networks (Figure 2A and 3A), whereas no significant changes were apparent 
in the thalamic RSFC network (Figure 4A). RSFC strength in various anatomical ROIs within 
these RSFC networks, have been shown previously to decrease after TBI when compared 
to sham. 13 RSFC strength was estimated from the frontal and parietal cortical, 
hippocampal and thalamic ROIs from the vehicle and Kaempferol-treated TBI groups. 
Kaempferol treatment led to significant increases in RSFC strength when compared to 
vehicle over multiple anatomical ROIs spanned by the somatosensory cortical RSFC 
network (Figures 2B). A similar Kaempferol-induced increase in RSFC strength was 
observed across multiple ROIs spanned by the hippocampal RSFC network (Figures 3B).  As 
observed by the relatively larger statistical clusters in the ipsilateral hemisphere adjoining 
the injury site between vehicle and Kaemferol treated TBI animal groups (arrows; Figures 
2C and 3C), Kaempferol was found to reduce the inter-hemispheric asymmetry in the 
somatosensory cortical and hippocampal RSFC networks. 
fMRI measures of cerebrovascular reactivity (CVR) were obtained using a transient (3 
min) inhalation of 10% CO2 gas mixture to induce hypercapnia as a vasodilatory stimulus.  
CVR maps, reporting on regional vasomotive functions were obtained on a voxel-wise 
manner basis based on fMRI-BOLD response amplitude to the CO2 stimulus as assessed by 
our previous studies. 13  While sham animals had a significantly higher global CVR 
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compared to untreated-TBI as assessed by our previous studies, 13  the current results 
assessing Kaempferol effects against TBI showed no significant effect on the CVR when 
compared to vehicle-treated TBI animals (Figure 5).  Quantitative statistical comparisons 
using a t-test between vehicle and Kaempferol groups, performed voxel-wise throughout 
the brain, did not reveal any significant clusters of altered CVR (data not shown).  
Discussion 
 Kaempferol dose used in the present study was in the range of human dietary intake of 
flavonol rich foods28  and  1000 times lower than the human safety limits of 1000 mg/Kg. 29   No 
significant differences were observed in mortality between vehicle and Kaempferol treated 
TBI animals. As a natural flavonoid compound, Kaempferol has been shown to specifically act 
on the mitochondrial Ca2+ uniporter (mCU) channel by enhancing it activity in vitro, 14  and 
capable of crossing the blood brain barrier. 30  Low-dose acute Kaempferol treatments in 
vivo (ie., 1mg/Kg i.v) have demonstrated its neuroactive effects of boosting stimulus-
induced neurovascular coupling, 31,32 neuronal electrical activity and the baseline oxidative 
metabolism in the normal brain. 32  Studying Kaempferol’s mechanism of action in vivo, 
comparable doses of 1mg/Kg i.p Kaempferol treatments were made during the 
acute/subacute window (1, 24 and 48 hours post-TBI) and assessed in vivo using the rat 
model of developmental TBI. 16  This early Kaempferol treatment mitigated the TBI-
induced brain energy metabolic decline, improved neural viability and behavior at 72 
hours post injury. 16 A metabolome-wide analysis of the brain indicated that Kaempferol’s 
effects in the post-TBI brain was predominantly via its action on mitochondria-related 
biochemical pathways. 16  Kaempferol’s mitochondrially-mediated effects including early 
bioenergetic stress mitigation after TBI, significantly altered the trajectory of 
developmental TBI at adolescence. Such a long-term beneficial effect on TBI prognosis was 
supported by our Kaempferol treatment studies, which improved behavioral and 
stimulation-induced cerebral blood flow (CBF) responses at adolescence (2 months after 
TBI). 17   
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Mitochondrial heterogeneity and the hypothesis of differential treatment outcomes 
across brain compartments and regions. 
While the in vivo treatment studies have so far established Kaempferol’s 
mitochondrial mechanism of action, neuroactive impact in the working brain and 
beneficial effects in developmental TBI outcomes, 16,31-33  its overall systemic impact within 
the brain can be hypothesized to vary depending on mitochondrial structural and 
functional heterogeneity across various cellular populations.  Brain regional mitochondrial 
heterogeneity and its placement within the context of cellular, functional, developmental 
and neuroanatomical environment are crucial to interpret pediatric brain 
pathophysiological changes. Additionally active consideration of mitochondrial 
heterogeneity, which is the true in vivo scenario, may help reconcile the differential impact 
of mitochondrially targeted treatments across various brain compartments. 34  Hence 
Kaempferol-induced mitochondrial functional changes and its consequent downstream 
impact on cellular pathways was hypothesized to manifest in a heterogeneous manner in a 
variety of cellular populations.  The current multimodal imaging design with clinically 
relevant markers enabled testing across cellular compartments and brain regions.  
Different multimodal imaging outcome results demonstrate the heterogeneous impact of 
mitochondrially targeted Kaempferol treatment across different cell types of the brain in 
vivo. 
Neuronal (synaptic/non-synaptic) and astroglial mitochondrial impact  35 
RSFC topology was significantly improved across the somatosensory cortical and 
hippocampal but not thalamic networks after Kaempferol treatments signifying a favorable 
outcome on the neuronal mitochondrial compartments (Figures 2,3 and 4). Both synaptic 
and non-synaptic mitochondria seem to be affected as observed from the increases in FA 
(Figure 1A and 1B) and somatosensory cortical RSFC network topology and strength 
(Figure 2). Earlier studies with the same dose of Kaempferol showed improved 
stimulation-induced cerebral blood flow (CBF) responses, suggesting improved neural 
circuit activity and neurovascular coupling. 17 As astrocytes significantly enable the 
neurovascular coupling process, their mitochondria are likely to have been impacted 
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leading to better astrocytic Ca2+ signaling and neurovascular activity.  As Ca2+ overload 
occurs in the temporal window of approximately 6 hours after TBI through mitochondrial 
dysfunction and arrest of Ca2+ transport, 36 the ion homeostatic benefits derived by both 
neuronal and astroglial mitochondria from Kaempferol treatment to improve their viability 
and function. However, the intensity of Kaempferol action is likely to vary depending on 
the functional differences of neuronal and astroglial mitochondria. Even across neurons, 
both synaptic and non-synaptic mitochondria may derive different Kaempferol treatment 
benefits with synaptic mitochondria receiving a higher impact. This possibility is due to a 
relatively greater TBI-induced oxidative damage of synaptic mitochondria when compared 
to non-synaptic. 35 Further heterogeneous effects could be observed in the thalamic RSFC 
network which showed no significant impact of Kaempferol (Figure 4), contrasting the 
robust neural connectivity improvements within the somatosensory cortical (Figure 2) and 
hippocampal RSFC networks (Figure 3).  
Although the thalamic region is very functionally diverse containing several nuclei 
with specific functions, the individual thalamic RSFC networks obtained from the six seed 
voxels placed randomly in different locations within the thalamic ROI has been shown to 
be topologically stable as demonstrated our earlier study. 26  Hence spatially separated 
selection of the 6 random seed voxels within all ROIs, including the thalamic ROI, was 
unlikely to cause any significant RSFC variability resulting in no improvement of thalamic 
RSFC after Kaempferol treatment.  Thalamic regions also do not display 
neurodegeneration, but show gradual neuronal atrophy from early perisomatic axotomy 
after a diffuse brain injury, very similar to our current model. 37 The subsequent post-TBI 
reorganization of the thalamus is also complex, leading to hypersensitivity in 
somatosensory responses and hypothesized as a maladaptive reorganization extending 
into the chronic time periods after TBI. 38 A diminishing RSFC spatial extent and strength in 
the ipsilateral thalamic regions at adolescence corroborate prior neuronal atrophic 
evidence. 37 However, Kaempferol’s inability to improve thalamic RSFC strength, in the 
current study, may point to a differently vulnerable mitochondrial population supporting a 
prolonged neural atrophic mechanism.  
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Endothelial and smooth muscle mitochondria impact 39,40  
Extracellular mitochondria after a central nervous system (CNS) injury have been 
proposed as a cellular rescue signal 41, and demonstrated to improve endothelial function 
in vivo after a stroke. 42 Although endothelial mitochondrial properties can be expected to 
differ from neural mitochondria in certain specific functions, they would generally benefit 
from Kaempferol treatment since the mitochondrial Ca2+ uniporter channel (mCU), which 
is the target for Kaempferol is expressed in all mitochondrial types.  While it is not known if 
mCU densities varied across various distinct cellular mitochondria within the CNS, 
enhanced survival capability of extracellular endothelial mitochondria from damaged 
vasculature can potentially alter the overall endothelial population responses post TBI in a 
beneficial direction. Supporting this view, improved stimulation-induced neurovascular 
activity after TBI suggest that the capillaries of the neurovascular units functioned better 
after Kaempferol treatment 17.   However, no significant improvement was observed in 
CVR in response to a transient hypercapnic challenge, which predominantly tests the 
functionality of large and intermediate cerebral arteries 43,44. The current result infers that 
smooth muscle mitochondria and hence their function was the least affected by 
Kaempferol treatment. Supporting this result, regional baseline CBF perfusion deficits after 
TBI, stemming from mostly large and intermediate vessel disruptions after injury, were 
observed to persist through development in the current model of TBI. 17  Kaemferol 
treatment, although helpful in improving behavioral and brain responses, had no effect on 
the decreased baseline CBF perfusion observed ipsilateral to the TBI. 17  Decreased CBF is a 
hallmark of concussive TBI in humans. 45  and its acute vascular origins and cellular 
mechanisms have been well studied in preclinical animal models of TBI of various severity.  
46 While chronic vascular rearrangement continues beyond 6 months after TBI with 
significant vessel proliferation in both the lesional and perilesional regions, there are no 
direct correlation between CBF and regenerated vessel density. 47  Furthermore, prolonged 
inflammation, BBB disruption and white matter damage may sustain chronic microvascular 
dysfunctions after TBI. 48 Recent studies indicate impaired myogenic constriction of 
cerebral arteries through mitochondrial oxidative stress after a TBI, which was restored by 
mitoTEMPO, a mitochondria-targeted antioxidant. 49 Hence TBI-induced mitochondrial 
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responses maybe very different in vascular cells, necessitating entirely different doses of 
Kaempferol for optimal effects.  Higher doses of Kaempferol is known to induce significant 
antioxidative and anti-inflammatory responses. Hence, future dose escalation studies may 
help determine possibilities of cerebrovascular protection through mitochondrially 
triggered redox- and immuno-modulations. 
To determine vehicle effects within the brain, untreated and vehicle-treated TBI 
animal comparisons were made in our earlier study, which showed no significant vehicle-
induced effects on the brain metabolome. 2 Hence vehicle treated sham group was not 
considered in the current study. Furthermore, given Kaempferol’s properties as a dietary 
flavonol compound with proven safety in humans, 28  it is highly unlikely that Kaempferol 
may have significant effects on the structural or functional components within the normal 
working brain.  Hence the absence of a Kaempferol-treated sham group in the current 
study, although a moderate weakness, is very unlikely to alter the overall conclusion of the 
study. 
Conclusion 
As TBI pathology is broad, its prognosis and treatment outcomes can be best 
understood multi-dimensionally using a systems approach spanning the genomic, 
proteomic, metabolomic, tissue, organ and organism levels. 50 The demonstrated 
multimodal translational imaging of TBI treatment and its ability to distinguish 
mitochondrial treatment responses across various tissue compartments and regions 
indicates its critical value within this futuristic systems framework.  While the Kaempferol 
dose used in the current preclinical trial favorably impacted neural populations, a lack of 
cerebrovascular improvement and minimal neural impact in the thalamic region indicated 
mitochondrial functional diversity. The current results justify future Kaempferol 
dose/treatment window optimizations extending to cerebrovascular protection, with 
potential to further enhance the improved behavioral and brain responses after TBI.   
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Figure captions 
 
Figure 1. Diffusion tensor imaging (DTI) group average of fractional anisotropy (FA) and 
apparent diffusion coefficient (ADC) in TBI animals treated with Kaempferol and vehicle. A. 
FA (TBI+Kaempferol>TBI+vehicle), B. ADC (TBI+vehicle>TBI+Kaempferol). Significant 
difference determined by a two-way t-test corrected for multiple comparisons. Voxels with 
t-values >2; corresponding to a corrected P<0.05 are significantly different TBI+Kaempferol 
vs TBI+vehicle (depicted by color statistical overlay on the rat brain atlas registered 
anatomical image). ROIs enclosing the corpus callosum, cingulum and internal capsule 
were used to average voxel-level and group-level parameters of C. FA and D. ADC. 
Significant Kaempferol-induced microstructural changes as determined by FA and ADC was 
observed in the corpus callosum.  Cingulum and internal capsule across both hemispheres 
also showed significant Kaempferol-induced FA changes. Unpaired two-tailed t-test with 
P<0.05 required for significance. Arrows indicate the location of fluid percussion TBI. 
  
D
ow
nl
oa
de
d 
by
 U
c 
Ri
ve
rs
id
e 
Li
br
ar
ie
s U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 R
iv
er
sid
e 
fro
m
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 1
2/
19
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Page 24 of 29 
 
 
 
24 
Jo
ur
na
l o
f N
eu
ro
tr
au
m
a 
Ka
em
pf
er
ol
 tr
ea
tm
en
t a
ft
er
 T
BI
 d
ur
in
g 
ea
rly
 d
ev
el
op
m
en
t m
iti
ga
te
s b
ra
in
 p
ar
en
ch
ym
al
 m
ic
ro
st
ru
ct
ur
e 
an
d 
ne
ur
al
 fu
nc
tio
na
l c
on
ne
ct
iv
ity
 d
et
er
io
ra
tio
n 
at
 a
do
le
sc
en
ce
 (D
O
I: 
10
.1
08
9/
ne
u.
20
19
.6
48
6)
 
Th
is 
pa
pe
r h
as
 b
ee
n 
pe
er
-r
ev
ie
w
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
 
Figure 2. Resting state functional connectivity (RSFC) maps obtained from the vehicle and 
Kaempferol treated TBI animal groups. Six random seeds from the right somatosensory 
cortical ROI was used from each subject. Cortical RSFC networks were obtained after cross 
correlating the seed voxel fMRI-BOLD time series with the signal time series across all 
voxels in the brain and subsequently averaged across trials and animals within each group 
after Fisher Z-transform. Voxels with average correlation coefficients (cc) >0.2; 
corresponding to a corrected P<0.05 represented active voxels of the cortical RSFC 
network. A. TBI+vehicle group, B. TBI+Kaempferol group. C. Significant difference 
determined by a two-way t-test corrected for multiple comparisons between 
TBI+Kaempferol and TBI+vehicle groups. Voxels with t-values >2; corresponding to a 
corrected P<0.05 are significantly different (depicted by the color statistical overlay on the 
rat brain atlas registered anatomical image). D. RSFC strength determined after averaging 
the cc values from the frontal and parietal cortical and hippocampal ROIs from either 
hemisphere in the Kaempferol and vehicle treated TBI groups. Kaempferol (n=8) 
significantly improved RSFC strength when compared to vehicle (n=5) across all ROIs 
except hippocampus on both hemispheres. Unpaired two-tailed t-test with P<0.05 
required for significance. Arrows indicate the location of fluid percussion TBI. 
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Figure 3. Resting state functional connectivity (RSFC) maps obtained from the vehicle and 
Kaempferol treated TBI animal groups. Six random seeds from the right hippocampal ROI 
was used from each subject. Hippocampal RSFC networks were obtained after cross 
correlating the seed voxel fMRI-BOLD time series with the signal time series across all 
voxels in the brain and subsequently averaged across trials and animals within each group 
after Fisher Z-transform. Voxels with average correlation coefficients (cc) >0.2; 
corresponding to a corrected P<0.05 represented active voxels of the hippocampal RSFC 
network. A. TBI+vehicle group, B. TBI+Kaempferol group. C. Significant difference 
determined by a two-way t-test corrected for multiple comparisons between 
TBI+Kaempferol and TBI+vehicle groups. Voxels with t-values >2; corresponding to a 
corrected P<0.05 are significantly different (depicted by the color statistical overlay on the 
rat brain atlas registered anatomical image). D. RSFC strength determined after averaging 
the cc values from the frontal and parietal cortical and dorsal hippocampal ROIs from 
either hemisphere in the Kaempferol and vehicle treated TBI groups. Kaempferol (n=8) 
significantly improved RSFC strength when compared to vehicle (n=5) in the frontal and 
parietal cortices across both hemisphere and the contralateral hippocampus. Unpaired 
two-tailed t-test with P<0.05 required for significance. Arrows indicate the location of fluid 
percussion TBI. 
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Figure 4. Resting state functional connectivity (RSFC) maps obtained from the vehicle and 
Kaempferol treated TBI animal groups. Six random seeds from the right thalamic ROI was 
used from each subject. Thalamic RSFC networks were obtained after cross correlating the 
seed voxel fMRI-BOLD time series with the signal time series across all voxels in the brain 
and subsequently averaged across trials and animals within each group after Fisher Z-
transform. Voxels with average correlation coefficients (cc) >0.2; corresponding to a 
corrected P<0.05 represented active voxels of the cortical RSFC network. A. TBI+vehicle 
group, B. TBI+Kaempferol group. C. RSFC strength determined after averaging the cc 
values from the frontal and parietal cortical and thalamic ROIs from either hemisphere in 
the Kaempferol and vehicle treated TBI groups. Kaempferol (n=8) although with greater 
average RSFC strength when compared to vehicle (n=5) across all ROIs showed no 
significant differences. Unpaired two-tailed t-test with P<0.05 required for significance. 
Arrows indicate the location of fluid percussion TBI. 
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Figure 5. Cerebrovascular reactivity response to transient (10%) carbon dioxide inhalation 
in A. TBI+vehicle (n=5), B. TBI+Kaempferol (n=8). Significant difference test for 
cerebrovascular reactivity differences between the vehicle and Kaempferol treated TBI 
groups were determined by a two-way t-test corrected for multiple comparisons yielded 
no significant clusters. Arrows indicates the site of fluid percussion TBI. A two-way t-test 
corrected for multiple comparisons between Kaempferol- and vehicle-treated TBI groups 
was performed and voxels with t-values >2; corresponding to a corrected P<0.05 was used 
as a significance threshold.  The TBI+Kaempferol vs TBI+vehicle group comparisons 
revealed no voxel clusters of significant differences (figure panel not shown). 
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Supplementary Figure Caption: 
 
Figure S1.  Typical high-resolution sham T1 anatomical image linearly registered to the 
average sham rat brain template along with the various ROIs drawn after identification 
from the rat brain atlas. 
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Figure S2. Group maps of DTI based FA and ADC during vehicle and Kaempferol treated 
conditions. A. FA vehicle group, B. FA Kaempferol treatment group, C. ADC vehicle group 
and D. ADC Kaempferol treated group. Areas exhibiting significant differences after 
Kaempferol treatment as obtained by statistical parametric mapping in Figures 1A and 1C 
and described in results text are overlaid in color identifying the specific anatomical 
regions. Unilateral increases in FA were mostly within the ipsilateral perirhinal cortex, 
hippocampus, hypothalamus, thalamus and amygdala. However, bilateral FA increases 
were observed across motor, somatosensory cortices, insula and caudate putamen after 
Kaempferol treatment. Although ADC decrease (panel D) were relatively sparse compared 
to FA increase (panel B), highly specific ADC decreases occurred across ipsilateral cortical 
regions, hippocampus and bilaterally across the hypothalamus. Arrows indicate the 
location of fluid percussion TBI.  
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